ANN ARBORAn experimental drug combined with the traditional chemotherapy drug cisplatin, when used in mice, destroyed a rare form of salivary gland tumor and prevented a recurrence within 300 days, a University of Michigan study found.
Called adenoid cystic carcinoma, or ACC, this rare cancer affects 3,000-4,000 people annually, and typically arises in the salivary glands. Its usually diagnosed at an advanced stage, is very resistant to therapy, and theres no cure. People may have read about ACC in the news lately, because elite professional runner Gabe Grunewald is currently undergoing her fourth round of treatment since her 2009 ACC diagnosis.
Typically, oncologists treat ACC tumors with surgery and radiation. They rarely use chemotherapy because ACC is extremely slow-growing, and chemotherapy works best on cancers where cells divide rapidly and tumors grow quickly, said Jacques Nr, a U-M professor of dentistry, otolaryngology and biomedical engineering, and principal investigator on the study.
The Nr lab treated ACC tumors with a novel drug called MI-773, and then combined MI-773 with traditional chemotherapy cisplatin. MI-773 prevents a molecular interaction that causes tumor cells to thrive by disarming the critical cancer fighting protein, p53.
Study co-author Shaomeng Wang, U-M professor of medicine, pharmacology and medicinal chemistry, discovered MI-773, which is currently licensed to Sanofi.
Researchers believe that blocking that interaction sensitized ACC cancer cells to cisplatina drug that under normal conditions, wouldnt work. When administered to the mice with ACC tumors, the cisplatin targeted and killed the bulk cells that form the tumor mass, while MI-773 killed the more resistant cancer stem cells that cause tumor recurrence and metastasis.
This drug MI-773 prevents that interaction, so p53 can induce cell death, Nr said. In this study, when researchers activated p53 in mice with salivary gland cancer, the cancer stem cells died.
The key is that in many other types of cancer, p53 is mutated so it cant kill cancer cells, and this mutation renders the MI-773 largely ineffective. However, in most ACC tumors p53 is normal, and Nr said researchers believe this makes these tumors good candidates for this combined therapy.
Researchers performed two different types of experiments to test ACC tumor reduction and recurrence. First, they treated tumors in mice with a combination of MI-773 and cisplatin, and tumors shrank from about the size of an acorn to nearly zero.
In the second experiment, the acorn-sized tumors were surgically removed, and for one month the mice were treated with MI-773 only, with the hope of eliminating the cancer stem cells that fuel recurrence and metastasis.
We did not observe any recurrence in the mice that were treated with this drug after 300 days (about half of mouse life expectancy), and we observed about 62 percent recurrence in the control group that had only the surgery, Nr said. Its our belief that by combining conventional chemotherapy with MI-773, a drug that kills more cancer stem cells, we can have a more effective surgery or ablation.
One limitation of the study is that its known that about half of all ACC tumors recur only after about 10 years, and this observational period was only 300 days.
In a typical metastasis, the cancer cells spread through the blood to other parts of the body. But ACC cancer cells like to move by crawling along nerves, and its common for ACC tumor cells to follow the prominent facial nerves to the brainpicture a mountain climber ascending a ropewhere its often fatal.
Research is still too early-stage to know how humans will respond, and the drug will work primarily in tumors where p53 is normal. If p53 is mutated, which is fairly common in other tumor types, this drug wont work as well, Nr said.
The work was funded by the Adenoid Cystic Carcinoma Research Foundation, U-M and the National Institutes of Health.
The study, Therapeutic Inhibition of the MDM2-p53 interaction prevents recurrence of adenoid cystic carcinomas, appeared earlier this year in the journal Clinical Cancer Research.
More information:
Here is the original post:
Combination of traditional chemotherapy, new drug kills ...
- New drug candidate uses novel absorption method to target cancer cells in mice - Michigan Medicine - August 22nd, 2022
- Jianping Fu Mechanical Engineering - University of Michigan - July 11th, 2022
- Cell Culture Market Key Drives Zeroing In On The Main Merchants | Danaher Corporation, Thermo Fisher Scientific Designer Women - Designer Women - July 11th, 2022
- Erasing The Stigma Of Sickle Cell Disease Through Advocacy - Essence - June 22nd, 2022
- This One Group Of People Holds The Key To Staying Young, Study Says Eat This Not That - Eat This, Not That - May 2nd, 2022
- Primary Cells Market 2022 is set to experience a significant growth rate | PromoCell GmbH, HemaCare Corporation, Thermo Fisher Scientific ... - May 2nd, 2022
- 3D Cell Culture Market to 2030 | Industry Statistics, Emerging Demands, Forecast to 2030 | 3D Biotek, LLC Advanced Biomatrix, Inc. Becton, Dickinson... - May 2nd, 2022
- Oral Cavity | histology - University of Michigan - April 19th, 2022
- Unraveling Stem Cells' Secrets: Immortality of Germline Cells and the Function of Junk DNA - SciTechDaily - April 19th, 2022
- Scientists De-Aged a Woman's Skin Cells by 30 Years - The Daily Beast - April 19th, 2022
- Longboat residents recall the greatest gifts - YourObserver.com - December 24th, 2021
- Nebraska Athletics News: Recruiting Season, Living Robots and Stuck in IKEA - Corn Nation - December 10th, 2021
- Duke Faculty Promoted or Appointed to the Rank of Full Professor - Duke Today - November 8th, 2021
- Lab-Growing Everything Might Be The Only Way To Attain A Sustainable World - Intelligent Living - November 8th, 2021
- Male Infertility Could Be Treated With Monkey Cells; New Study Shows How These Animals Could Help Address the Condition - Science Times - October 28th, 2021
- Insights & Outcomes: Place cells, planarians, and 'prewet' proteins - Yale News - October 28th, 2021
- Using a mini heart model to develop new therapies - MSUToday - October 5th, 2021
- Rowan University hosts National Science Foundation research program for undergrads - Rowan Today - August 31st, 2021
- Loss of a top autism gene may alter neuron structure - Spectrum - January 17th, 2021
- Rogel team receives $11.2M to leverage the microbiome against GVHD - Newswise - October 28th, 2020
- Latest Update 2020: What Are the Key Players Evolving In the Growth of the 3D Cell Culture Market? - re:Jerusalem - October 28th, 2020
- Listings - CON, THE on ABC | TheFutonCritic.com - The Futon Critic - October 15th, 2020
- ABC News Debuts New Primetime Series THE CON Narrated by Whoopi Goldberg - Broadway World - October 8th, 2020
- HOME GROWN: Pumpkins best left on the vine for as long as possible - The Oakland Press - October 8th, 2020
- Official Missteps in Michigan's Worst Covid Prison Outbreak - The Intercept - September 29th, 2020
- Regenerative medicine and war: The next breakthrough in treating injured veterans? - Genetic Literacy Project - September 29th, 2020
- Hematopoietic Stem Cells (HSCs) Market Primary Research, Secondary Research, Product Research, Trends And Forecast By 2026- Kite Pharma Inc., Thermo... - September 29th, 2020
- New research connects the hormones we're born with to lifetime risk for immunological diseases - MSUToday - September 20th, 2020
- School of Science grows by 10 - MIT News - September 10th, 2020
- COVID-19 Drug Discovery and Development Why Diverse Strategies Are Critical - Technology Networks - September 10th, 2020
- Researchers identify environmental components that affect gene expression in cardiovascular disease - The South End - June 21st, 2020
- Hesperos Human-on-a-Chip used to model Alzheimer's and MCI - SelectScience - June 2nd, 2020
- Are immune-compromised kids at greater risk from Covid-19? - Health24 - May 3rd, 2020
- Erika Hersch-Green Wins CAREER Award for Biodiversity Research - Michigan Tech News - May 2nd, 2020
- Science Becomes A Dividing Issue In Year Of Election And Pandemic - Michigan Radio - May 2nd, 2020
- In a CRISPR first, Editas therapy used to fix genes in the body - BioPharma Dive - March 11th, 2020
- Stopping Smoking Allows Healthy Lung Cells to Proliferate - Medscape - February 8th, 2020
- After a bone injury, shape-shifting cells rush to the rescue - University of Michigan News - January 29th, 2020
- Engineer the future of human health with a PhD in biomedical engineering - Study International News - January 29th, 2020
- The Unexpected Diversity of Pain - Scientific American - January 24th, 2020
- BREAKING: A woman gives birth to the Son of God (Part II) - INQUIRER.net - January 5th, 2020
- Collaborative Robots: Rai... - Robotics Online - December 19th, 2019
- VetStem Biopharma Shares the Success Story of Jesse Who was Treated with VetStem Cell Therapy - PR Web - December 8th, 2019
- Stem Cell Therapy Michigan | Regenerative Medicine 248-216 ... - February 27th, 2019
- Stem Cell Treatments Bloomfield Hills, MI | 248-216-1008 - January 9th, 2019
- Michigan Integrative Health Dr. Roy Picard, D.C. - December 27th, 2018
- Breast Cancer Stem Cells Stopping Them In Their Tracks ... - November 23rd, 2018
- Stem Cell Treatments MI | Michigan Center for Renerative ... - November 2nd, 2018
- Michigan Stem Cell Therapy - Foot HealthCare Associates - November 2nd, 2018
- Cancer Stem Cell Research | University of Michigan Rogel ... - November 2nd, 2018
- University of Michigan Stem Cell Research | Treatment and ... - November 2nd, 2018
- Detroit Michigan Stem Cell Therapy - americanregen.com - September 28th, 2018
- Stem Cells FAQ Michigan Stem Cell Institute - August 29th, 2018
- Anti-Aging, Regeneration and Stem Cell Supplements - August 7th, 2018
- Families raise money for research into rare diseases - KARE - September 8th, 2017
- Cells that stand in the way of HIV cure: Discovery expands understanding of marrow's role - Medical Xpress - August 5th, 2017
- Turmeric and black pepper fight cancer stem cells - November 26th, 2016
- Michigan company mines stem cells in search of Fountain of ... - November 18th, 2016
- stem cell research | Michigan Radio - October 6th, 2016
- Stem Cell Therapy Treatment at Allure Medical Spa in Michigan - October 6th, 2016
- University of Michigan Stem Cell Research | Experts List - September 20th, 2016
- Five years after Michigan vote on human embryonic stem ... - August 26th, 2016
- Scientists coax stem cells to form 3-D mini lungs ... - August 11th, 2016
- Cancer stem cells - University of Michigan Comprehensive ... - July 25th, 2016
- Michigan Catholic Conference: Home - October 19th, 2015
- Michigan Stem Cell Amendment, Proposal 2 (2008 ... - July 2nd, 2015
- University of Michigan Stem Cell Research | Embryo Donation - May 12th, 2015
- University of Michigan Stem Cell Research | Stem Cell ... - April 22nd, 2015
- How to grow a human lung - March 25th, 2015
- Novogen (NVGN) Promising Data in Brain Cancer; eFuture Information Technology (EFUT) and ... - March 5th, 2015
- Stem Cell Research - Right to Life of Michigan - February 24th, 2015
- Breast Cancer Stem Cell Research - University of Michigan ... - January 17th, 2015
- What makes pancreatic cancer so aggressive? New study sheds light - January 16th, 2015
- Leukemia Stem Cell Research | University of Michigan ... - January 4th, 2015
- Seeing Is Believing - December 12th, 2014
- Swiston receives Commitment to Education Award - November 29th, 2014
- Bone marrow registration drive to be held at Saint Mary's College - November 18th, 2014
- Researchers devise a means for growing near 2-D chemical gardens (w/ Video) - November 11th, 2014
- Stem cells help doctors restore womans smile, regenerating bone to hold dental implants - November 5th, 2014
- Reason to Bree-Lieve: Greenville girl continues to beat the odds - November 5th, 2014